Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy

Rationale. The aim of this study is to evaluate sex hormones abnormalities and incidence of polycystic ovary syndrome among young women with epilepsy, analyzing the possible impact of antiepileptic therapy. Material and methods. In this study we included 41 women with epilepsy, aged between 18 to 4...

Full description

Bibliographic Details
Main Authors: Corina Roman-Filip, Aurelian Ungureanu, Ciprian Rociu, Florin Grosu, Ovidiu Bajenaru
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2013-03-01
Series:Romanian Journal of Neurology
Subjects:
Online Access:https://rjn.com.ro/articles/2013.1/RJN_2013_1_Art-03.pdf
_version_ 1811242709935980544
author Corina Roman-Filip
Aurelian Ungureanu
Ciprian Rociu
Florin Grosu
Ovidiu Bajenaru
author_facet Corina Roman-Filip
Aurelian Ungureanu
Ciprian Rociu
Florin Grosu
Ovidiu Bajenaru
author_sort Corina Roman-Filip
collection DOAJ
description Rationale. The aim of this study is to evaluate sex hormones abnormalities and incidence of polycystic ovary syndrome among young women with epilepsy, analyzing the possible impact of antiepileptic therapy. Material and methods. In this study we included 41 women with epilepsy, aged between 18 to 40 years, not receiving hormones, with disease duration for 1 to 15 years. The assessment included clinical examination, transvaginal ultrasonography and measurement of sex hormones serum concentration (total testosterone, estradiole, SHBG, LH and FSH) from days 1 to 10 of one menstrual cycle. The patients were compared with a healthy control group. Hormonal data were correlated with the concomitant antiepileptic therapy. Results. PCO (polycystic ovaries) were found in 19 patients (46%) associated frequently with valproate treatment started before the age of 20 years. PCOS (polycystic ovary syndrome) was found in 20% of the patients, also under valproate therapy. In 22 patients (53%), a high serum testosterone level (19 patients under valproate mono- or add-on therapy). LH/FSH ratio appears bigger than 1 in 21 patients (51%) (17 patients treated with valproate mono- or add-on therapy). Conclusions. The endocrine - reproductive dysfunctions occurred more frequently in epileptic women treated with valproate; these endocrine abnormalities may have a negative impact on fertility in women with epilepsy and therefore young patients should be screened and carefully evaluated in an endocrinology service prior to start the antiepileptic treatment.
first_indexed 2024-04-12T13:55:51Z
format Article
id doaj.art-758e8b681ea64e2fbd45c3666875dd63
institution Directory Open Access Journal
issn 1843-8148
2069-6094
language English
last_indexed 2024-04-12T13:55:51Z
publishDate 2013-03-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Neurology
spelling doaj.art-758e8b681ea64e2fbd45c3666875dd632022-12-22T03:30:23ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942013-03-01121242910.37897/RJN.2013.1.3Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapyCorina Roman-Filip0Aurelian Ungureanu1Ciprian Rociu2Florin Grosu3Ovidiu Bajenaru4Department of Neurology, “Lucian Blaga” University, SibiuDepartment of Neurology, “Lucian Blaga” University, SibiuDepartment of Neurology, “Lucian Blaga” University, SibiuDepartment of Neurology, “Lucian Blaga” University, SibiuDepartment of Neurology, University of Medicine and Pharmacy “Carol Davila”, BucharestRationale. The aim of this study is to evaluate sex hormones abnormalities and incidence of polycystic ovary syndrome among young women with epilepsy, analyzing the possible impact of antiepileptic therapy. Material and methods. In this study we included 41 women with epilepsy, aged between 18 to 40 years, not receiving hormones, with disease duration for 1 to 15 years. The assessment included clinical examination, transvaginal ultrasonography and measurement of sex hormones serum concentration (total testosterone, estradiole, SHBG, LH and FSH) from days 1 to 10 of one menstrual cycle. The patients were compared with a healthy control group. Hormonal data were correlated with the concomitant antiepileptic therapy. Results. PCO (polycystic ovaries) were found in 19 patients (46%) associated frequently with valproate treatment started before the age of 20 years. PCOS (polycystic ovary syndrome) was found in 20% of the patients, also under valproate therapy. In 22 patients (53%), a high serum testosterone level (19 patients under valproate mono- or add-on therapy). LH/FSH ratio appears bigger than 1 in 21 patients (51%) (17 patients treated with valproate mono- or add-on therapy). Conclusions. The endocrine - reproductive dysfunctions occurred more frequently in epileptic women treated with valproate; these endocrine abnormalities may have a negative impact on fertility in women with epilepsy and therefore young patients should be screened and carefully evaluated in an endocrinology service prior to start the antiepileptic treatment.https://rjn.com.ro/articles/2013.1/RJN_2013_1_Art-03.pdfepilepsyendocrine – reproductive dysfunctionsantiepileptic drugs
spellingShingle Corina Roman-Filip
Aurelian Ungureanu
Ciprian Rociu
Florin Grosu
Ovidiu Bajenaru
Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
Romanian Journal of Neurology
epilepsy
endocrine – reproductive dysfunctions
antiepileptic drugs
title Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
title_full Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
title_fullStr Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
title_full_unstemmed Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
title_short Endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
title_sort endocrine reproductive dysfunctions in women with epilepsy on antiepileptic therapy
topic epilepsy
endocrine – reproductive dysfunctions
antiepileptic drugs
url https://rjn.com.ro/articles/2013.1/RJN_2013_1_Art-03.pdf
work_keys_str_mv AT corinaromanfilip endocrinereproductivedysfunctionsinwomenwithepilepsyonantiepileptictherapy
AT aurelianungureanu endocrinereproductivedysfunctionsinwomenwithepilepsyonantiepileptictherapy
AT ciprianrociu endocrinereproductivedysfunctionsinwomenwithepilepsyonantiepileptictherapy
AT floringrosu endocrinereproductivedysfunctionsinwomenwithepilepsyonantiepileptictherapy
AT ovidiubajenaru endocrinereproductivedysfunctionsinwomenwithepilepsyonantiepileptictherapy